India’s first generic drug for cancer treatment launched

Cancer treatment drug launch

Medicine Capsule
Picture: Pixabay

Last Updated on December 8, 2021 by The Health Master

Mumbai-based BDR Pharma has announced the launch of India’s first generic- Midostaurin under the brand name MSTARIN, which is indicated in rare, hard-to-treat cancers.

The drug is approved for use in combination with standard Daunorubicin & Cytarabine induction and high-dose Cytarabine consolidation chemotherapy

And for patients in complete response followed by Midostaurin single-agent maintenance therapy for adults with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation-positive.

The drug will have a strength of 25 mg, in the form of capsules.

BDR Pharma launches Antibiotics to treat these infections

Natco Pharma launches FDC Trifluridine & Tipiracil first time in India

MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy

A portable Hydrogen inhaler launched: Dual-use technology

Lupin launches generic Fenofibrate capsules for this ailment

Sun Pharma launches acne treatment cream

NPPA fixes retail price of 20 formulations: December 2021

IPC adds these 9 new IP impurities standards

Lok Sabha passes NIPER (Amendment) Bill 2021

India and Pharmacy Education: Chapter: 10

68 cases of unapproved Fixed Dose Combinations reported during 2017-21

100 crore drug racket: Accused transported drugs in vehicle with Chandigarh number plate

NPPA fixes retail price of 2 formulations: November 2021

Procedure to obtain license for Commercial Testing Laboratories

NPPA fixes retail price of 47 formulations: November 2021

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner